NDC Package 0053-7202-02 Zemaira

.alpha.1-proteinase Inhibitor Human Kit - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0053-7202-02
Package Description:
1 KIT in 1 CARTON * 76 mL in 1 VIAL, SINGLE-USE (0053-7212-01) * 76 mL in 1 VIAL, SINGLE-USE (0053-7653-80)
Product Code:
Proprietary Name:
Zemaira
Non-Proprietary Name:
.alpha.1-proteinase Inhibitor Human
Usage Information:
This medication is used to treat lung problems (emphysema) caused by a certain inherited disease (alpha-1-proteinase inhibitor deficiency). In people with this condition, lung damage is caused by elastase, a natural substance that the body needs to kill bacteria in the lungs. Normally, a protein (alpha-1-proteinase inhibitor) stops elastase from working when it is no longer needed. However, in people who do not make enough of this protein, elastase does not stop working and damages the lungs. This medication replaces the missing alpha-1-proteinase inhibitor and helps to prevent further lung damage.
11-Digit NDC Billing Format:
00053720202
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
  • RxCUI: 1661208 - alpha 1-proteinase inhibitor, human 1 MG Injection
  • RxCUI: 991722 - Zemaira 1 MG Injection
  • RxCUI: 991722 - alpha 1-proteinase inhibitor, human 1 MG Injection [Zemaira]
  • Product Type:
    Plasma Derivative
    Labeler Name:
    Csl Behring Llc
    Dosage Form:
    Kit - A packaged collection of related material.
    Sample Package:
    No
    FDA Application Number:
    BLA125078
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    04-24-2019
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0053-7202-02?

    The NDC Packaged Code 0053-7202-02 is assigned to a package of 1 kit in 1 carton * 76 ml in 1 vial, single-use (0053-7212-01) * 76 ml in 1 vial, single-use (0053-7653-80) of Zemaira, a plasma derivative labeled by Csl Behring Llc. The product's dosage form is kit and is administered via form.

    Is NDC 0053-7202 included in the NDC Directory?

    Yes, Zemaira with product code 0053-7202 is active and included in the NDC Directory. The product was first marketed by Csl Behring Llc on April 24, 2019 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0053-7202-02?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units.

    What is the 11-digit format for NDC 0053-7202-02?

    The 11-digit format is 00053720202. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20053-7202-025-4-200053-7202-02